- 1、本文档共11页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
1279 cases of pulmonary tuberculosis drug susceptibility test results re-analysis of
PAGE \* MERGEFORMAT 11
1279 cases of pulmonary tuberculosis drug susceptibility test results re-analysis of
Authors: Feng Sujuan ZHAO Li-Xue Xu Xue-wen
【Abstract】 Objective: Drug-resistant Mycobacterium tuberculosis clinical treatment has been a major problem as well as re-treatment of refractory one of the main TB. Reported in the literature are significant differences between high and low resistance rates around, we have summed up the 1996 to 2005, 10-year period 1279 cases of drug-resistant tuberculosis patients re-treated hospitalized experimental results, to understand the rate of drug resistance in Wuhan, in order to provide reference for clinical treatment. Results: 1279 cases of drug resistance in 678 cases of drug resistance rate was 53.0%. Of which 172 cases of resistance to one drug, accounting for 25.4% of the number of drug-resistant cases; 169 cases of resistance to two drugs, accounting for 24.94%; followed by 124 cases for the three drugs, accounting for 18.3%; four drugs in 74 cases, accounting for 11.0%; 5 drugs 58 cases, accounting for 8.6%; 6 drug 42 cases, accounting for 6.2%; 7 drugs 40 cases, accounting for 5.9%. Reported in the literature SM, INH, RFP three kinds of drug resistance rates higher than other drugs, and has been among the top three. This phenomenon is due to H, S, R 3 kinds of drugs in chemotherapy is difficult to replace with other drugs caused. Conclusion: The treatment of multi-drug resistant cases are quite difficult, its efficacy difference is one of the reasons causing refractory tuberculosis.
Keywords: drug-resistant tuberculosis, resistance rates
Retreatment of tuberculosis, drug resistant strains refractory to their great relationship. Reported in the literature re-treatment of people with low resistance rates accounted for 41.4%, accounting for 94.0% of high, significant differences between high and low. In some areas of the initial drug-resistant TB has also reached 92.4%. We have summar
您可能关注的文档
- 1 case of malignant mesothelioma multi-site.doc
- 1 case of male breast cancer aged.doc
- 1 case of liver cirrhosis and portal hypertension in patients with splenectomy plus cholecystectomy nursing of postoperative bleeding.doc
- 1 case of methimazole induced acute care of patients with blood stagnation.doc
- 1 case of Kawasaki disease complicated by deafness.doc
- 1 case of myopathy clinical and pathological analysis.doc
- 1 case of myositis ossificans axillary.doc
- 1 case of misdiagnosis and mistreatment of choriocarcinoma.doc
- 1 case of nasal meningioma.doc
- 1 case of lumbar spinal stenosis surgery for 6 lessons.doc
- 2025年成都市玩偶生产荧光涂鸦互动玩偶开发可行性研究报告.docx
- 2025年成都市海绵生产用于体育馆室外运动场地透水改造可行性研究报告.docx
- 2025年天津市体操鞋企业团建运动应用报告.docx
- 2025年上海市溶洞极限运动(速降)场地开发可行性研究报告.docx
- 2025年上海市涵洞工程施工技术应用可行性研究报告.docx
- 2025年上海市体育场馆设施扎带安全防护可行性研究报告.docx
- 2025年上海市牦牛育肥产业园区建设可行性研究报告.docx
- 2025年旅拍宠物陪伴拍摄项目可行性研究报告.docx
- 2025年上海市进口食品节庆主题快闪店可行性研究报告.docx
- 2025年上海市洗选厂尾矿综合利用产业化可行性研究报告.docx
最近下载
- GB15763.1-2009 建筑用安全玻璃 第1部分:防火玻璃 (2).pdf VIP
- DB5101T 217—2025成都市城市绿化养护技术规程.pdf
- 漫画解读--非煤露天矿山重大事故隐患判定标准.pdf
- 伤口、造口、失禁性皮炎理论考试试题与参考答案.docx VIP
- LNG气化站安装工程施工的方案.doc VIP
- 2023年8月26日全国事业单位联考A类《职业能力倾向测验》真题.pdf VIP
- 跨境电子商务英语 课件 柯可 Unit 1 Overview of Cross-Border E-Commerce、 Unit 2 Main Cross-Border E-Commerce Platforms.pptx
- 2024年辅警招聘《公安工作基本知识》培训考试题库 (附答案).docx VIP
- 低氧对肝脏脂质代谢影响研究.docx VIP
- GB T 34986-2017 产品加速试验方法.doc VIP
文档评论(0)